<code id='039862F077'></code><style id='039862F077'></style>
    • <acronym id='039862F077'></acronym>
      <center id='039862F077'><center id='039862F077'><tfoot id='039862F077'></tfoot></center><abbr id='039862F077'><dir id='039862F077'><tfoot id='039862F077'></tfoot><noframes id='039862F077'>

    • <optgroup id='039862F077'><strike id='039862F077'><sup id='039862F077'></sup></strike><code id='039862F077'></code></optgroup>
        1. <b id='039862F077'><label id='039862F077'><select id='039862F077'><dt id='039862F077'><span id='039862F077'></span></dt></select></label></b><u id='039862F077'></u>
          <i id='039862F077'><strike id='039862F077'><tt id='039862F077'><pre id='039862F077'></pre></tt></strike></i>

          Home / explore / comprehensive

          comprehensive


          comprehensive

          author:fashion    Page View:6123
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In